EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

IL-6 as a Mediator of Platelet Hyper-Responsiveness

Connor Elliot Webb iD, Jordan Vautrinot, Ingeborg Hers iD

Cells · 2025

DOI: 10.3390/cells14110766 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cells, 2025. Verfasst von Connor Elliot Webb und 2 weiteren Autor:innen. Beteiligte Einrichtung: School of Physiology, Pharmacology and Neuroscience, Biomedical Sciences Building, University Walk, Bristol BS8 1TD, UK. Hauptthemen laut MEDLINE: Interleukin-6, Blood Platelets. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 215 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: British Heart Foundation, Biotechnology and Biological Sciences Research Council (BBSRC), BHF.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Interleukin-6 (IL-6) is a pleiotropic cytokine with critical roles in immune regulation, inflammation, and haematopoiesis. While its functions in host defence and tissue repair are well established, accumulating evidence suggests that IL-6 also can directly and indirectly modulate megakaryocyte and platelet biology. This review examines the mechanistic basis supporting IL-6-mediated platelet hyper-responsiveness, in addition to its effect on megakaryopoiesis and thrombopoiesis in thromboinflammatory disease states. We discuss how IL-6-mediated trans-signalling may sensitizes platelets to activation, and that this may be exclusive to glycoprotein VI (GPVI) stimulation due to Janus kinase (JAK)–signal transducer 2 crosstalk, in addition to other mechanisms that may contribute to priming platelets. We further highlight clinical evidence linking IL-6 to thrombotic complications in cardiovascular disease and infection (e.g., COVID-19 and sepsis). Given the emerging interest in IL-6-targeting therapies as anti-inflammatory and anti-thrombotic agents, a thorough understanding of how IL-6 can drive platelet responsiveness is crucial.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Interleukin-6Blood PlateletsHumansCOVID-19Signal TransductionThrombopoiesisAnimalsPlatelet ActivationMegakaryocytesThrombosisSARS-CoV-2

Stichwörter der Autor:innen

hyper-responsivenessinterleukin-6plateletsthrombo-inflammationthrombosis

Substanzen

Interleukin-6

Autor:innen und Institutionen

  • School of Physiology, Pharmacology and Neuroscience, Biomedical Sciences Building, University Walk, Bristol BS8 1TD, UK.

ORCID-Profile: Connor Elliot Webb, Ingeborg Hers

Förderung

  • British Heart Foundation
  • Biotechnology and Biological Sciences Research Council (BBSRC)
  • BHF
  • BBSRC

Zitieren

APA

Webb, C. E., Vautrinot, J., & Hers, I. (2025). IL-6 as a Mediator of Platelet Hyper-Responsiveness. Cells. https://doi.org/10.3390/cells14110766

Vancouver

Webb CE, Vautrinot J, Hers I. IL-6 as a Mediator of Platelet Hyper-Responsiveness. Cells. 2025. doi:10.3390/cells14110766

BibTeX
@article{Webb2025,
  author = {Webb, Connor Elliot and Vautrinot, Jordan and Hers, Ingeborg},
  title = {IL-6 as a Mediator of Platelet Hyper-Responsiveness},
  journal = {Cells},
  year = {2025},
  doi = {10.3390/cells14110766}
}
Kostenlos starten →